293 related articles for article (PubMed ID: 36525231)
21. Oligometastatic non-small cell lung cancer: a narrative review of stereotactic ablative radiotherapy.
Dohopolski M; Iyengar P
Ann Palliat Med; 2021 May; 10(5):5944-5953. PubMed ID: 33691460
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of primary disease (breast, non-small cell lung and prostate cancers) with irradiation in case of de novo metastatic cancer].
Latorzeff I; Bourgier C; Pinel B; Hennequin C; Jimenez G; Chapet O; Zasadny X
Cancer Radiother; 2019 Oct; 23(6-7):486-495. PubMed ID: 31501025
[TBL] [Abstract][Full Text] [Related]
23. Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinion.
Hendriks LEL; Dooms C; Berghmans T; Novello S; Levy A; De Ruysscher D; Hasan B; Giaj Levra M; Giaj Levra N; Besse B; Vansteenkiste J; Dingemans AC;
Eur J Cancer; 2019 Dec; 123():28-35. PubMed ID: 31655358
[TBL] [Abstract][Full Text] [Related]
24. Radiation therapy for oligometastatic non-small cell lung cancer.
Salama JK; Schild SE
Cancer Metastasis Rev; 2015 Jun; 34(2):183-93. PubMed ID: 25948377
[TBL] [Abstract][Full Text] [Related]
25. The management of oligometastatic disease in colorectal cancer: Present strategies and future perspectives.
Carconi C; Cerreti M; Roberto M; Arrivi G; D'Ambrosio G; De Felice F; Di Civita MA; Iafrate F; Lucatelli P; Magliocca FM; Picchetto A; Picone V; Catalano C; Cortesi E; Tombolini V; Mazzuca F; Tomao S
Crit Rev Oncol Hematol; 2023 Jun; 186():103990. PubMed ID: 37061075
[TBL] [Abstract][Full Text] [Related]
26. Is it too early to recommend local treatment in oligometastatic non-small cell lung cancer: a plea for equipoise.
Ahmad I; Chufal KS; Miller AA; Bajpai R; Umesh P; Dawer A; Tandon S; Gandhidasan S; Dua B; Bhatia K; Gairola M
Br J Radiol; 2024 May; 97(1157):913-919. PubMed ID: 38538948
[TBL] [Abstract][Full Text] [Related]
27. Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intent.
Buglione M; Jereczek-Fossa BA; Bonù ML; Franceschini D; Fodor A; Zanetti IB; Gerardi MA; Borghetti P; Tomasini D; Di Muzio NG; Oneta O; Scorsetti M; Franzese C; Romanelli P; Catalano G; Dell'Oca I; Beltramo G; Ivaldi GB; Laudati A; Magrini SM; Antognoni P;
Lung Cancer; 2020 Mar; 141():1-8. PubMed ID: 31926440
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases: Findings From the NRG-BR001 Phase 1 Trial.
Chmura S; Winter KA; Robinson C; Pisansky TM; Borges V; Al-Hallaq H; Matuszak M; Park SS; Yi S; Hasan Y; Bazan J; Wong P; Yoon HA; Horton J; Gan G; Milano MT; Sigurdson ER; Moughan J; Salama JK; White J
JAMA Oncol; 2021 Jun; 7(6):845-852. PubMed ID: 33885704
[TBL] [Abstract][Full Text] [Related]
29. Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases.
Al-Hallaq HA; Chmura S; Salama JK; Winter KA; Robinson CG; Pisansky TM; Borges V; Lowenstein JR; McNulty S; Galvin JM; Followill DS; Timmerman RD; White JR; Xiao Y; Matuszak MM
Pract Radiat Oncol; 2016; 6(6):e291-e298. PubMed ID: 27345129
[TBL] [Abstract][Full Text] [Related]
30. Stereotactic body radiation therapy: A good dance partner of oligometastatic non-small cell lung cancer to the sound of SINDAS study.
Mielgo-Rubio X; Garde-Noguera J; Juan O; Couñago F
World J Clin Oncol; 2020 Dec; 11(12):983-989. PubMed ID: 33437660
[TBL] [Abstract][Full Text] [Related]
31. Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy.
Nicosia L; Cuccia F; Mazzola R; Ricchetti F; Figlia V; Giaj-Levra N; Rigo M; Tomasini D; Pasinetti N; Corradini S; Ruggieri R; Alongi F
Strahlenther Onkol; 2020 Sep; 196(9):813-820. PubMed ID: 32399637
[TBL] [Abstract][Full Text] [Related]
32. Endoscopic nodal staging in oligometastatic non-small cell lung cancer (NSCLC) being treated with stereotactic ablative radiotherapy (ENDO-SABR).
Dhaliwal I; Kassirian S; Mitchell MA; Qiabi M; Warner A; Louie AV; Wong HH; McDonald CM; Rajchgot J; Palma DA
BMC Cancer; 2022 Apr; 22(1):468. PubMed ID: 35484614
[TBL] [Abstract][Full Text] [Related]
33. Treatment Strategies for Oligometastatic Breast Cancer.
Nesbit EG; Donnelly ED; Strauss JB
Curr Treat Options Oncol; 2021 Aug; 22(10):94. PubMed ID: 34426881
[TBL] [Abstract][Full Text] [Related]
34. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.
Ball D; Mai GT; Vinod S; Babington S; Ruben J; Kron T; Chesson B; Herschtal A; Vanevski M; Rezo A; Elder C; Skala M; Wirth A; Wheeler G; Lim A; Shaw M; Schofield P; Irving L; Solomon B;
Lancet Oncol; 2019 Apr; 20(4):494-503. PubMed ID: 30770291
[TBL] [Abstract][Full Text] [Related]
35. Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer.
Juan O; Popat S
Clin Lung Cancer; 2017 Nov; 18(6):595-606. PubMed ID: 28377206
[TBL] [Abstract][Full Text] [Related]
36. Stereotactic body radiotherapy (SBRT) for Stage I lung cancer.
Nagata Y; Kimura T
Jpn J Clin Oncol; 2018 May; 48(5):405-409. PubMed ID: 29635536
[TBL] [Abstract][Full Text] [Related]
37. A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).
Radwan N; Phillips R; Ross A; Rowe SP; Gorin MA; Antonarakis ES; Deville C; Greco S; Denmeade S; Paller C; Song DY; Diehn M; Wang H; Carducci M; Pienta KJ; Pomper MG; DeWeese TL; Dicker A; Eisenberger M; Tran PT
BMC Cancer; 2017 Jun; 17(1):453. PubMed ID: 28662647
[TBL] [Abstract][Full Text] [Related]
38. A critical review of recent developments in radiotherapy for non-small cell lung cancer.
Baker S; Dahele M; Lagerwaard FJ; Senan S
Radiat Oncol; 2016 Sep; 11(1):115. PubMed ID: 27600665
[TBL] [Abstract][Full Text] [Related]
39. Development of a Prognostic Model for Overall Survival in Patients With Extracranial Oligometastatic Disease Treated With Stereotactic Body Radiation Therapy.
Chen H; Poon I; Atenafu EG; Badellino S; Biswas T; Dagan R; Erler D; Foote M; Redmond KJ; Ricardi U; Sahgal A; Louie AV
Int J Radiat Oncol Biol Phys; 2022 Dec; 114(5):892-901. PubMed ID: 34890753
[TBL] [Abstract][Full Text] [Related]
40. Approach to Oligometastatic Cancer in the Elderly Patient.
Winter IW; Smile TD; Videtic GMM
Curr Oncol Rep; 2021 Aug; 23(11):122. PubMed ID: 34448967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
